Fischer Imaging

Fischer Imaging is a development stage company focused on improving breast cancer imaging and diagnosis. With a legacy dating back over a century, it was one of the oldest U.S. manufacturers of x-ray equipment, and has achieved pioneering milestones in the field of digital mammography and mammography guided stereotactic biopsy. The company's current product pipeline includes MammoSound, which offers fusion mammography-ultrasound imaging for improved breast cancer screening and diagnosis, MammoCAT, featuring slot scanning mammography and tomosynthesis for enhanced resolution and contrast with reduced radiation dosage and minimized breast compression, and Mammo360, providing full 360-degree 3D mammography and stereotactic breast biopsy without breast compression. Founded in 2016, Fischer Imaging operates within the biotechnology, hardware, and healthcare sectors. Although specific headquarters and recent investment details are undisclosed, the company’s slogan “Better imaging, Better outcomes” reflects its commitment to advancing medical imaging technologies for improved patient outcomes.